Patient profiles and metabolic outcomes after switching from TAFcontaining, INSTI-based triple antiretroviral therapy to dolutegravir-based two-drug regimens.
Initiation of dolutegravir plus lamivudine in ART-naive adults with high HIV-1 viral load or severe immunosuppression: prevalence of use and efficacy versus DTGor BIC-based triple therapy